On 21 March, HLB Life Science announced a rights offering capital raise worth 150 billion won. The expected rights offering price is 13,630 won (32% lower than current price of 19,930 won).
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.